In the methods section, reference is made to the validation of FRS in Malaysia. It is not clear if the calculation was adjusted for the demographic structure of the Malaysian population. Also the data is not adjusted for cluster effects by the 9 clinics. At least the IntraCluster Correlation Coefficient ( ICC) should be calculated for the outcome.
One of the most interesting findings was the over-estimation by ethnicity in both the provider and patient data. The reference category is "bumiputra" and other. This needs to be clarified especially for the international audience (explaining how bumiputra is different from Malay).
This finding also should be discussed in more detail in the discussion as should the other forms of bias. The very low correlation between provider and patient estimates also needs discussion.
You can only state in comparison with the risk estimated by Framingham risk score. Please change this throughout the paper.
Minor: -Why did you choose to include patients from 35 years. By European guidelines it is not recommended to start CVD risk evaluation at that young age, is it different in the Asian guidelines? -the conclusion in the abstract is unclear and should be rephrased -page 5, line 45: why did you not record use of anti-hypertensive medication? -did you perform repetitive blood pressure measurements? -statistics: how many did you exclude due to missing values? did you consider to do multiple imputation? -again, patients included were 35-86 years, it is problematic to perform risk estimations in the young and very old. Please discuss.
-Page 10, line 21: this is a cross-sectional study, not prospective - Comment 3 Also the data is not adjusted for cluster effects by the 9 clinics. At least the Intra-Cluster Correlation Coefficient ( ICC) should be calculated for the outcome.
Reply 3
We did not adjust for the cluster effect and have added the following sentence to the limitations for clarity: There was no adjustment for cluster effect or multicollinearity.
Comment 4
One of the most interesting findings was the over-estimation by ethnicity in both the provider and patient data. The reference category is "bumiputra" and other. This needs t o be clarified especially for the international audience (explaining how bumiputra is different from Malay).
Reply 4 Thank you for this comment. Bumiputera can refer to both Malays and indigenous natives. We had used the term previously to refer to non-Malay bumiputera but this can mislead the reader as you have pointed out. We have therefore revised the term to 'indigenous' for clarity in Table 1 ,3 and 5. We have also changed the reference group to Malay in the regression to improve clarity as the Malay ethnicity was the largest group in the study population.
Comment 5 This finding also should be discussed in more detail in the discussion as should the other forms of bias. The very low correlation between provider and patient estimates also needs discussi on.
Reply: We have added the following to the Discussion Section. Patients appeared to be more aware of family history and having a higher waist circumference as conferring risk compared to other risk factors. Family history and obesity have been shown to be associated with increased self-perception of risk.12 It is useful to identify factors that have greater meaning to patients. Otherwise, a mismatch between doctors' and patients' perception on the importance of particular risk factors can affect the communication of risk. The very low correlation between provider and patient estimates that we found in this study indicates that this mismatch is occurring. Ethnicity also was found to be significantly associated with underestimation of risk. It is unclear as to why this should occur. This finding can be used to target those at greater risk of inaccurate estimations for intervention.
Reviewer: 2 SHC Michigan State University, USA Please state any competing interests or state 'None declared': None declared Please leave your comments for the authors below This study was aimed to examine how accurately patients and physicians estimate CV risk of patients in primary care, which is interesting and contributes to the literature. However, the manuscript has major flaws to consider. 1. In abstract, line 36-57. the authors were not consistent to report the results. They used directional words, such as higher waist circumference, younger age, higher HDL, but some times they used nondirectional words, such as ethnicity. Please be consistent to report the results.
Reply: 1. As there is no directional word for ethnicity, we have added that the reference group is Malay. We have also changed the reference group to Malay in the regression to improve clarity as t he Malay ethnicity was the largest group in the study population.
They did not report the statistical results appropriately.
Reply: I will describe more details below.
3. line 57. AOR and CI are missing for ethnicity.
Reply: 3. We have added the AOR and CI for ethnicity in the abstract. 4. Page 3. line 15. This study is not a prospective study. It is a cross -sectional study.
Reply: 4. Thank you for your comments. We have revised the manuscript accordingly.
5. One of the major flaw is that the authors did not explain how they measure patients' and physicians' estimation of CV risk, even though it is the primary variable.
Reply: 5. The following has been added to the Methods section: Patients were asked to rate their risk of having a heart attack or stroke within the next 10 years as being low, moderate or high. The doctors then filled in patients' data on smoking status in the last one month, history of diabetes and hypertension, lipid profile within the last one year, statin and antiplatelet use, and estimated patients' CVD risk in the next 10 years as per usual practice namely low (<10%), moderate (10-20%) and high (>20%).
6. page 4, line 32-37. the sentence "the proliferation of mobile health technology..." is not relevant to this study.
Reply: 6. This line was added to show that most of the studies were done nearly a decade ago when resources were not widely available. The availability of apps to easily calculate the risk should have aided in the risk estimation. However this was not the case. Reply:v 8. We have revised the line accordingly. Patients with known cardiovascular diseases (CVD) for example ischaemic heart disease and strokes were excluded. 9. Page 6. According to Table 3 and 5, the authors looked like they performed logistic regression (reported ORs). But there is no mention about this statistical method.
Reply: 9. The following was added to the Methods Section. Univariate and multivariate binary logistic analyses were used, with underestimation of those at high risk as the outcome of interest.
10. I am concerned about the logistic regression model, if the authors performed. In Table 5 , they included systolic BP, diastolic BP, as well as hypertension in one model. I assumed these 3 variables be highly correlated. Did the authors examine any multicollinearity? if so, please provide evidence.
Reply: 10. We did not check for multicollinearity. Adjustment for multicollinearity would likely only make the results more significant and so we included all the variables in the multivariate regression model. We have included this as a limitation.
11. The other major concern I have is that the authors did not interpret the tables appropriately. For example, page 7, line 48. "younger age" is related to underestimation. But the OR is bigger than 1. it should be "older age" is related to underestimation. This is not the only case the authors misinterpreted the findings. About half of the findings were misinterpreted. Also, Table 3 shows that higher systolic BP is related to underestimation of CV risk, which is different from the literature. The authors should discuss about this.
Reply: 11. Thank you for this observation. We realise that we have put in the regression table where underestimation was put as the reference value and not the dependent outcome. We have now put in the appropriate table which shows the factors and the adjusted odds ratio for underestimation of CV risk by the doctors.
12. There is not mention about consent form.
Reply: 12. The following was added to the section regarding Ethical Approval. Potential participants were given verbal and written information regarding the study and informed consent was obtained from those who were recruited.
Reviewer: 3 Silvia Rollefstad Diakonhjemmet Hospital, Oslo, Norway Please state any competing interests or state 'None declared': None declared Please leave your comments for the authors below
The authors have performed a moderate sized cross-sectional study to evaluate patients' and doctors CVD risk estimation compared to risk estimated by the Framingham risk score. Some issues need to be adressed:
Major: 1. It is not accurate to state that only 55.7 of the doctors correctly estimated the CVD risk. To be able to state this you need a prospective study with hard CVD endpoints. You can only state in comparison with the risk estimated by Framingham risk score. Please change this throughout the paper.
Reply: 1. As stated in the methods section, the Framingham risk score has been validated in our population and was therefore selected as the gold standard for comparison with estimations by the patients and doctors. We have included the following for clarity: Abstract: Only 34.4% of patients and 55.7% of doctors correctly estimated the patient's CVD risk in comparison to the reference score.
Methods:
Estimations made by the patients and doctors were deemed to be correct when there was agreement with the Framingham score as calculated by the research team; underestimation occurred when estimations were low or moderate in those scored as high risk by the research team.
Strengths and limitations:
This study used the validated Framingham risk score as the reference standard. Therefore, accuracy of estimations were based on agreement with the reference score and not to actual cardiovascular outcomes which would require a cohort study design. Minor: 2. Why did you choose to include patients from 35 years. By European guidelines it is not recommended to start CVD risk evaluation at that young age, is it different in the Asian guidelines?
Reply: 2. Present guidelines recommend that risk estimation be done from the ages of 40. For the Framingham risk score, it is recommend for use in those aged between 30-74. We chose to take those age 35 and up.
3. The conclusion in the abstract is unclear and should be rephrased Reply: 3. We have rephrased this as follows: The majority of consultations occurring between doctors and patients are being informed by inaccurate cardiovascular risk estimation. Inaccuracy is mainly due to underestimation of patients' CVD risks 4. page 5, line 45: why did you not record use of anti-hypertensive medication?
Reply: 4. The use of anti-hypertensive medication is a variable needed for the Framingham score and was actually recorded in our study. We have added this to the Methods section.
5. did you perform repetitive blood pressure measurements?
Reply: 5. No, this was a cross-sectional study.
6. statistics: how many did you exclude due to missing values? did you consider to do multiple imputation?
Reply: 6. There were only 4 missing values in the high risk group. This is a small number so we did not do multiple imputation.
7. again, patients included were 35-86 years, it is problematic to perform risk estimations in the young and very old. Please discuss.
Reply: 7. We included patients above the age of 75 although the recommended age range for the Framingham risk score is 30-74. This was to better reflect the patient population that is seen in the primary care setting. In order to clarify this, we have added the following to the Strengths and Limitations section: We included patients aged 75 and above although the Framingham risk score is recommended for those aged 30 to 74 years of age. This decision was taken as it reflects the actual patient population that is seen in primary care.
8.Page 10, line 21: this is a cross-sectional study, not prospective Reply: 8. We have changed the term prospective to cross-sectional.
9. Table 1 : Please comment on the very high proportion of persons with diabetes and hypertension Reply: 9. As stated in the Background section, cardiovascular disease is the leading cause of death worldwide and this problem is worse in developing countries. Non-communicable disease has overtaken acute and infectious diseases as the reason for primary care attendance in our country. This can be seen from our previous study as listed below: Ee, Ming Khoo and Ai, Theng Cheong and Su, May Liew and Wai, Khee Lee and Azah Abdul Samad, and Ainul NadzihaMohd Hanafiah, and Sondi Sararaks, (2015) The changing face of primary care: a cross sectional study in Malaysia. Sains Malaysiana, 44 (5). pp. 741-746.
VERSION 2 -REVIEW

REVIEWER
Mark Harris UNSW, Australia REVIEW RETURNED 05-Aug-2017
GENERAL COMMENTS
1. The authors have acknowledged in the discussion that they did not adjust for possible clustering. They should also provide an estimate of the ICC for at least one of the outcomes. as this may influence some of the associations that are only just significant (such as waist circumference).
2. The underestimation of risk by both patients and doctors for patients of Indian ethnicity warrants comment.
Minor corrections:
The first column in Table 3 is headed "SmoGenderg" . The row for Malay is now blank. 
REVIEWER
GENERAL COMMENTS
The authors addressed some of the reviewers' comment but not fully.
Page 2, line 16: I am still not sure about why you included only persons > 35 years of age. Page 38, line 34. "aged 75" --> "aged 35"
In Table 3 , why are gender, smoker, income, BP, cholesterol and many other factors not significant? These findings conflict with the literature. Please discuss these conflicts.
In table 3, the OR for the reference groups is 1. please add a "1" as the OR for the reference group. Please also indicate which group is the reference group. I assume that "hypertension yes", diabetes "yes".... is the reference group.
My major concern is their statistical analyses. Page 38, line 40: "There was no adjustment for cluster effect or multicollinearity". If there is high correlations among the variables (multicollinearity) and you ignore the correlations, then the analyses are no longer reliable. For example, in table 5, you had hypertension, systolic BP, and diastolic BP in one model, which I assumes multicollinearity would exist. Yet, you did not examine/adjust multicollinearity. Same thing with age and experience.
VERSION 2 -AUTHOR RESPONSE
Reviewer: 1 Reviewer Name: Mark Harris Institution and Country: UNSW, Australia Please state any competing interests or state 'None declared': None declared Please leave your comments for the authors below 1. The authors have acknowledged in the discussion that they did not adjust for possible clustering. They should also provide an estimate of the ICC for at least one of the outcomes as this may influence some of the associations that are only just significant (such as waist circumference).
Reply:
We have engaged the services of a consultant statistician to check on clustering and multicollinearity. The ICC was calculated for all the variables and ranged from 0.001 to 0.086 indicating that the clusters are homogenous.
We have added the following to the Analysis section:
The intracluster correlation coefficient (ICC) was calculated to determine the homogeneity of the clusters. Values of ICC that are close to 0 indicate that the design effect is 1 and that the clusters are homogenous. (Killip S, 2004 ).
The Results section:
The ICC values calculated for all the variables were small, ranging from 0.001 to 0.086, indicating that the clusters are homogenous.
The AOR for underestimation of doctors for patients of Indian ethnicity was 0.430, CI: 0.257, 0.720. It was not significant for underestimation by patients. This indicates that in comparison to the Malay patients, underestimation of risk by doctors was less in patients of Indian ethnicity. It is possible that this is linked to training that those of South Asian ethnicity are of higher risk.
